Accelerated Recovery Program for Early Discharge After Minimally Invasive Liver Surgery Using Robotic or Laparoscopic Techniques

What this Trial Is About

Researchers are evaluating an accelerated recovery program designed to shorten hospital stays for patients undergoing minimally invasive liver surgery, specifically lower complexity liver resections Kawaguchi-Gayet grade I. This study combines minimally invasive surgical methods, enhanced recovery after surgery ERAS protocols, and Telehealth to allow for earlier discharge while ensuring patient safety. The study also aims to understand patient experiences and barriers to adopting this recovery pathway more broadly. Participants will be randomly assigned to one of two groups. One group follows the accelerated recovery protocol, which encourages discharge on the day of surgery if certain criteria are met, including a clear liquid diet, independent walking, and minimized opioid use. They receive telehealth video visits on the first two days after surgery and an in-person clinic visit within 14 days. The other group undergoes the standard recovery pathway with overnight observation, gradual diet advancement, opioid weaning, and discharge once recovery milestones are met, followed by an in-person clinic visit within 14 days. Both groups complete about 14 questionnaires over 30 days to track recovery progress. During the study, participants will be closely monitored for adverse events using established criteria. Researchers will assess recovery through patient questionnaires and safety evaluations for approximately one year. The study requires participants to stay within 50 miles of the medical center immediately after surgery to ensure rapid care if needed. This comprehensive follow-up and assessment plan aims to gather detailed data on recovery outcomes and safety for patients undergoing minimally invasive liver surgery.

Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection